Feedback
  • Article / Essay
  • Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic…

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

Affiliation
Hunan Key Laboratory of Cancer Metabolism ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,Hunan ,China
Wang, Zhi-Bin;
Affiliation
Department of Gynecological Oncology ,Tongji Hospital ,Tongji Medical College ,Huazhong University of Science and Technology ,Wuhan ,China
Liu, Dan;
Affiliation
Department of Experimental Radiation Oncology ,The University of Texas MD Anderson Cancer Center ,Houston ,TX ,United States
Lei, Guang;
Affiliation
Department of Clinical Pharmacology ,Hunan Key Laboratory of Pharmacogenetics ,National Clinical Research Center for Geriatric Disorders ,Xiangya Hospital ,Central South University ,Changsha ,Hunan ,China
Liu, Zhao-Qian;
Affiliation
Hunan Key Laboratory of Cancer Metabolism ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,Hunan ,China
Wu, Nayiyuan;
Affiliation
Hunan Key Laboratory of Cancer Metabolism ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,Hunan ,China
Wang, Jing

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (09.06.2023)
Volume:
14
Date Issued:
09.06.2023
DOI:
10.3389/fphar.2023.1222209
Language:
English
Type of Resource:
Text
Keywords:
ovarian cancer; targeted medication; immunomodulatory; drug resistance; PARP inhibitors; anti-angiogenic drugs
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Wang, Liu, Lei, Liu, Wu and Wang.

Use and reproduction: